Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Clene Inc. Director's Dealing 2022

Feb 3, 2022

34487_dirs_2022-02-03_5be5d435-6d17-4383-a69a-fb89e1c5c2e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2022-02-01

Reporting Person: BROWN MORGAN R (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-01 Stock Options (Right to buy) $2.96 A 250000.00 Acquired 2032-02-01 Common Stock (250000.00) Direct

Footnotes

F1: This option was granted on February 1, 2022 as an option for 250,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.96 per share. The options vest with respect to the first 25% of such shares on February 1, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the last day of each calendar month, beginning February 1, 2023, until such shares are fully vested